Showing results (31-40 of 83) with videos related to
Sort By:
Pageof 9
Journal of Clinical Microbiology|January 1, 1992
Evaluation of a commercially available second-generation immunoglobulin G enzyme immunoassay for detection of Helicobacter pylori infectionH Goossens, Y Glupczynski, A Burette, et al.Journal of Clinical Microbiology|May 1, 1989
Semisolid blood-free selective-motility medium for the isolation of campylobacters from stool specimensH Goossens, L Vlaes, I Galand, et al.The British Journal of Venereal Diseases|October 1, 1978
In-vitro activity of antimicrobial agents against Neisseria gonorrhoeae in BrusselsR Vanhoof, M P Vanderlinden, J M Hubrechts, et al.Scandinavian Journal of Infectious Diseases|January 1, 1982
Cefotaxime therapy of serious infections with multiresistant gram-negative bacilliN Clumeck, Y van Laethem, R Vanhoof, et al.The Journal of Antimicrobial Chemotherapy|May 1, 1987
Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acidP De Mol, T Mets, R Lagasse, et al.The Journal of Antimicrobial Chemotherapy|July 1, 1983
Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infectionsN Clumeck, B Gordts, I Dab, et al.The British Journal of Venereal Diseases|February 1, 1982
In-vitro activity of 21 antimicrobial agents against Neisseria gonorrhoeae in BrusselsB Gordts, R Vanhoof, J M Hubrechts, et al.Infection|July 1, 1983
Moxalactam therapy of serious infectionsP Van der Auwera, N Clumeck, Y Van Laethem, et al.The Journal of Antimicrobial Chemotherapy|June 1, 1984
In-vitro susceptibility of salmonellae to antimicrobial agentsH Goossens, R Vanhoof, P De Mol, et al.Antimicrobial Agents and Chemotherapy|October 1, 1978
Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agentsR Vanhoof, M P Vanderlinden, R Dierickx, et al.Pageof 9